Predicting HIV Transmission Risk among HIV-Infected Patients Seen in Clinical Settings
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
We assessed risk of transmission among 4,016 HIV-infected patients in primary care, including men who have sex with men (MSM, n = 2,109), women (n = 1,104) and men who had sex with women (MSW, n = 803) in clinics in 15 cities across the U.S. A transmission risk act, assessed by computer assisted interviews, was defined as unprotected vaginal or anal sex with a partner who was HIV-uninfected or of unknown HIV status. MSM were more than twice as likely to report transmission risk acts than MSW (Odds Ratio [OR] = 2.35; 95% Confidence Interval [CI] = 1.84, 3.00; P ≤ .001). Women were also more likely to report transmission risk acts than MSW (OR = 1.56; 95% CI = 1.19, 2.05; P ≤ .001). Stimulant use was associated with transmission risk in all three groups (P ≤ .05). MSM were more likely to use methamphetamines (8% versus 2% and 3% respectively), while MSW (17%) and women (12%, compared to 11% for MSM) were more likely to use cocaine. Clinical settings offer opportunities for preventing HIV transmission, particularly if interventions are tailored to sub-populations of HIV-infected patients.
- Arnsten, J. H., Demas, P. A., Grant, R. W., Gourevitch, M. N., Farzadegan, H., Howard, A. A., et al. (2002). Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users. Journal of General Internal Medicine, 17(5), 377–381.
- CDC (2003). Advancing HIV Prevention: Interim Technical Guidance for Selected Interventions. Atlanta: CDC.
- Colfax, G., Coates, T. J., Husnik, M. J., Huang, Y., Buchbinder, S., Koblin, B., et al. (2005). Longitudinal patterns of methamphetamine, popper (amyl nitrite), and cocaine use and high-risk sexual behavior among a cohort of san francisco men who have sex with men. Journal of Urban Health, 82(1 Suppl 1), i62–i70.
- Colfax, G. N., Vittinghoff, E., Grant, R., Lum, P., Spotts, G., & Hecht, F. M. (2007). Frequent methamphetamine use is associated with primary non-nucleoside reverse transcriptase inhibitor resistance. AIDS, 21(2), 239–241. CrossRef
- Ellis, R. J., Childers, M. E., Cherner, M., Lazzaretto, D., Letendre, S., & Grant, I. (2003). Increased human immunodeficiency virus loads in active methamphetamine users are explained by reduced effectiveness of antiretroviral therapy. Journal of Infectious Diseases, 188(12), 1820–1826. CrossRef
- Fisher, J. D., Cornman, D. H., Osborn, C. Y., Amico, K. R., Fisher, W. A., & Friedland, G. A. (2004). Clinician-initiated HIV risk reduction intervention for HIV-positive persons: Formative Research, Acceptability, and Fidelity of the Options Project. Journal of Acquired Immune Deficiency Syndromes, 37(Suppl 2), S78–87.
- Gribble, J. N., Miller, H. G., Rogers, S. M., & Turner, C. F. (1999). Interview mode and measurement of sexual behaviors: methodological issues. Journal of Sex Research, 36, 16–24. CrossRef
- Halkitis, P. N., Parsons, J. T., & Stirratt, M. J. (2001). A double epidemic: crystal methamphetamine drug use in relation to HIV transmission among gay men. Journal of Homosexuality, 41(2), 17–35. CrossRef
- Health Resources and Services Administration HIV/AIDS Bureau. (2004). Ryan White CARE Act Data Summery. Rockville: MD August 2006.
- Hinkin, C. H. et al. (2007). Drug use and medication adherence among HIV-1 infected individuals. AIDS and Behavior, 11(2), 185–194. CrossRef
- Institute of Medicine (2001). No time to lose: getting more from HIV prevention. Washington, DC: National Academy of Sciences.
- Kalichman, S. C., Rompa, D., & Cage, M. (2005). Group intervention to reduce HIV transmission risk behavior among persons living with HIV/AIDS. Behavior Modification, 29(2), 256–285. CrossRef
- Kalichman, S. C., Rompa, D., Cage, M., DiFonzo, K., Simpson, D., Austin, J., et al. (2001). Effectiveness of an intervention to reduce HIV transmission risks in HIV-positive people. American Journal of Preventive Medicine, 21(2), 84–92. CrossRef
- Koblin, B. A., Chesney, M. A., Husnik, M. J., Bozeman, S., Celum, C. L., Buchbinder, S., et al. (2003). High-risk behaviors among men who have sex with men in 6 US cities: baseline data from the EXPLORE Study. American Journal of Public Health, 93(6), 926–932. CrossRef
- Lyles, C. M. et al. (2007). Best-evidence interventions: findings from a systematic review of HIV behavioral interventions for US populations at high risk, 2000–2004. American Journal of Public Health, 97(1), 133–143. CrossRef
- Morin, S. F., Koester, K. A., Steward, W. T., Maiorana, A., McLaughlin, M., Myers, J. J., et al. (2004). Missed Opportunities: Prevention With HIV-Infected Patients in Clinical Care Settings. Journal of Acquired Immune Deficiency Syndromes, 36(4), 960–966. CrossRef
- Morin, S. F., Steward, W. T., Charlebois, E. D., Remien, R. H., Pinkerton, S. D., Johnson, M. O., et al. (2005). Predicting HIV transmission risk among HIV-infected men who have sex with men: findings from the healthy living project. Journal of Acquired Immune Deficiency Syndromes, 40(2), 226–235. CrossRef
- Myers, J. J., Steward, W. T., Charlebois, E., Koester, K. A., Maiorana, A., & Morin, S. F. (2004). Written clinic procedures enhance delivery of HIV “Prevention With Positives” counseling in primary health care settings. Journal of Acquired Immune Deficiency Syndromes, 37(Suppl 2), S95–S100.
- Purcell, D. W. et al. (2004). Interventions for seropositive injectors-research and evaluation: an integrated behavioral intervention with HIV-positive injection drug users to address medical care, adherence, and risk reduction. Journal of Acquired Immune Deficiency Syndromes, 37(Suppl 2), S110–118
- Richardson, J. L., Milam, J., McCutchan, A., Stoyanoff, S., Bolan, R., Weiss, J., et al. (2004). Effect of brief safer-sex counseling by medical providers to HIV-1 seropositive patients: a multi-clinic assessment. AIDS, 18(8), 1179–1186. CrossRef
- Rotheram-Borus, M. J., Swendeman, D., Comulada, W. S., Weiss, R. E., Lee, M., & Lightfoot, M. (2004). Prevention for Substance-Using HIV-Positive Young People: Telephone and In-Person Delivery. Journal of Acquired Immune Deficiency Syndromes, 37(Suppl 2), S68–77.
- Steward, W. T., Koester, K. A., Myers, J. J., & Morin, S. F. (2006). Provider fatalism reduces the likelihood of HIV-prevention counseling in primary care settings. AIDS and Behavior, 10(1), 3–12. CrossRef
- The Healthy Living Project Team (2007). Effects of a behavioral intervention to reduce risk of transmission among people living with HIV: the healthy living project randomized controlled study. Journal of Acquired Immune Deficiency Syndromes, 44(2), 213–221. CrossRef
- Turner, C. F., Ku, L., Rogers, S. M., Lindberg, L. D., Pleck, J. H., & Sonenstein, F. L. (1998). Adolescent sexual behavior, drug use, and violence: increased reporting with computer survey technology. Science, 280(5365), 867–873. CrossRef
- Weinhardt, L. S., Kelly, J. A., Brondino, M. J., Rotheram-Borus, M. J., Kirshenbaum, S. B., Chesney, M. A., et al. (2004). HIV transmission risk behavior among men and women living with HIV in 4 cities in the United States. Journal of Acquired Immune Deficiency Syndromes, 36(5), 1057–1066. CrossRef
- Westbrook, L., & Bauman, L. (1996). Perceived stigma of HIV/AIDS: Public view. Bronx, NY: Albert Einstein College of Medicine.
- Wingood, G. M., DiClemente, R. J., Mikhail, I., Lang, D. L., McCree, D. H., Davies, S. L., et al. (2004). A randomized controlled trial to reduce HIV transmission risk behaviors and sexually transmitted diseases among women living with HIV: The WiLLOW Program. Journal of Acquired Immune Deficiency Syndromes, 37(Suppl 2), S58–67.
- Wolitski, R. J., Gomez, C. A., & Parsons, J. T. (2005). Effects of a peer-led behavioral intervention to reduce HIV transmission and promote serostatus disclosure among HIV-seropositive gay and bisexual men. AIDS, 19(Suppl 1), S99–109.
- Wolitski, R. J., Parsons, J. T., Gomez, C. A., Purcell, D. W., Hoff, C. C., & Halkitis, P. N. (2005). Prevention with gay and bisexual men living with HIV: rationale and methods of the Seropositive Urban Men’s Intervention Trial (SUMIT). AIDS, 19(Suppl 1), S1–11. CrossRef
- Predicting HIV Transmission Risk among HIV-Infected Patients Seen in Clinical Settings
AIDS and Behavior
Volume 11, Issue 1 Supplement, pp 6-16
- Cover Date
- Print ISSN
- Online ISSN
- Springer US
- Additional Links
- HIV prevention with positives
- Clinical settings
- Transmission risk
- Industry Sectors